Skip to main content
OpenTrials
Completed

NCT Number: NCT01092273

Bimatoprost Versus Travoprost at Cairo University

Bimatoprost has been shown to provide effective IOP lowering in patients of all races. Conversely, travoprost has been shown to be more effective in black patients than in Caucasians in some studies. However, Noecker et al 2004 compared bimatoprost with travoprost in African-Americans with glaucoma or OHT, and found that bimatoprost was more likely than travoprost to achieve target pressure at 3 months.

These racial differences in efficacy of these medications warrant further investigations. The investigators study aim to compare the IOP-lowering efficacies of bimatoprost and travoprost in an Egyptian population with primary open-angle glaucoma (OAG) or ocular hypertension (OHT).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

20 year–72 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Cairo University

Cairo, Cairo Governorate, 11431, Egypt

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Glaucoma and Ocular Hypertension

Exclusion criteria

  • Any ocular disease or medication that may raise the intraocular pressure.

Treatment and study plan

Primary outcomes

  1. Percentage of intraocular pressure lowering of bimatoprost versus travoprost.

Secondary outcomes

  1. Rate of development of complications.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Bimatoprost Versus Travoprost in an Egyptian Population: A Hospital-Based Prospective Randomized Study.

Important dates

First posted
Mar 24, 2010
Registry last updated
Mar 24, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.